SPON1 is an independent prognostic biomarker for ovarian cancer.
Miyakawa R, Kobayashi M, Sugimoto K, Endo Y, Kojima M, Kobayashi Y, Furukawa S, Honda T, Watanabe T, Asano S, Soeda S, Hashimoto Y, Fujimori K, Chiba H.
Miyakawa R, et al.
J Ovarian Res. 2023 May 13;16(1):95. doi: 10.1186/s13048-023-01180-8.
J Ovarian Res. 2023.
PMID: 37179355
Free PMC article.